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Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the
coronavirus disease 2019 (COVID-19), is the causative infectious agent of the current
pandemic. As researchers and health professionals are still learning the capabilities of
this virus, public health concerns arise regarding the zoonotic potential of SARS-CoV-2.
With millions of people detected with SARS-CoV-2 worldwide, reports of companion
animals possibly infected with the virus started to emerge. Therefore, our aim is to review
reported cases of animals naturally infected with SARS-CoV-2, particularly companion
pets, shedding light on the role of these animals in the epidemiology of COVID-19.
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INTRODUCTION
SARS-CoV-2, or severe acute respiratory syndrome coronavirus 2 (1), is an emergent, zoonotic
pathogen first identified in China in late 2019 (2, 3). This enveloped, positive-sense single-stranded
RNA virus is a novel Betacoronavirus (4) with phylogenetic proximity to SARS-CoV-1 (2, 3). In
humans, SARS-CoV-2 can cause asymptomatic infections to severe atypical pneumonia that can
lead to death. Given its rapid spread in different countries, the disease, named COVID-19 (i.e.,
Coronavirus Disease 2019), was declared a Public Health Emergency of International Concern
by the World Health Organization (WHO) in January 2020 (5). In only 2 months, the virus
spread to all continents, except Antarctica, and in March 2020, COVID-19 was characterized by
WHO as a pandemic (5). On August 3, 2020, SARS-CoV-2 has been present in 213 countries or
regions and detected in at least 17 million people, while 690,000 individuals have succumbed to the
disease (6, 7).
According to the United States Agency for International Development (USAID), nearly 75%
of all new emerging or re-emerging infectious diseases of the last century originated in animals,
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such as HIV, Ebola, avian influenza, and swine influenza (8).
Accordingly, the initial epicenter of SARS-CoV-2 was linked to
possible contact with wild animals sold at wholesale seafood
and exotic animal markets of Huanan, Wuhan, Hubei province,
China (5). Analysis of complete genome sequences of the new
coronavirus isolated from patients during the initial stage of
the outbreak in Wuhan showed only about 79% identity with
SARS-CoV-1 (severe acute respiratory syndrome coronavirus
1), identified in China in 2002 (9, 10), and 50% identity with
MERS-CoV (Middle East respiratory syndrome coronavirus),
identified in Saudi Arabia in 2012 (4, 11). Interestingly, it
revealed 96% identity with a bat coronavirus (BatCoV) found
in Rhinolophus affinis (horseshoe bat), named RaTG13, sampled
in Yunnan province, China, in 2013 (12), and 91.02% identity
with a coronavirus obtained from pangolins (Manis javanica)
(13, 14). This close phylogenetic relatedness of SARS-CoV-2 to
non-human coronaviruses, in the absence of a known ancestral
virus sample, strongly suggests a viral host jump from wildlife
to humans, most likely from bats (12, 13, 15). More detailed
genomic analyses indicate that SARS-CoV-2 is a product of
natural selection rather than laboratory manipulation and that
an animal source was likely involved in the initial cases of human
infections associated with the Huanan market (15). Because
contact between humans and bats is a rare event, it is also
possible that a susceptible intermediate host species may have
participated in the epidemiology of SARS-CoV-2, similar to what
was observed with SARS-CoV-1 and MERS-CoV (16, 17).
Coronaviruses (CoVs) tend to be species specific when it
comes to hosts, which is determined by the interaction of the
virus with specific host cell receptors (18). The spike protein,
a protruding glycoprotein of the membrane of CoV virions,
mediates host cell adhesion and membrane fusion (18). The
amino acid sequence of the spike protein is what defines its
ability to interact with different host cell receptors. For three
of the human coronaviruses, HCoV-NL63, SARS-CoV-1, and
SARS-CoV-2, the angiotensin-converting enzyme 2 (ACE-2) has
been identified as the cell receptor with which the spike protein
interacts (19–22). For the adhesion to occur properly, researchers
have identified 69 amino acid residues at the receptor binding
domain (RBD) of the spike protein that are key for its interaction
with ACE-2 (22). Although both SARS-CoV-2 and SARS-CoV-
1 use the same receptor, their RBD is different at five out of six
important amino acid residues. Surprisingly, only one of these
residues was identical between SARS-CoV-2 and the BatCoV
RaTG13, while all six are identical between SARS-CoV-2 and
the pangolin CoV (23). Thus, although the BatCoV RaTG13 is
the closest relative to SARS-CoV-2 at the whole-genome level,
the RBD residues critical for receptor interaction are actually
identical to pangolin CoVs (23). This finding is supportive
evidence of a natural selection process during a viral host jump
from animals to humans.
As detailed above, the amino acid sequence of ACE-2 is a
determining factor of the host species range affected by SARS-
CoV-2. During the search for an animal model of COVID-19,
bioinformatic predictions and previous studies with SARS-CoV-
1 indicated that non-human primates, ferrets, hamsters, and
domestic cats were possible animal candidates to be explored
(24–28). Accordingly, experimental SARS-CoV-2 infection and
clinical sign development have been successfully accomplished
in non-human primates, ferrets, and golden Syrian hamsters
(Mesocricetus auratus) (27, 29–33). Experimental infection was
also successful in cats, but the animals developed no clinical
signs (31, 34). In dogs, the intranasal inoculation of SARS-
CoV-2 in 3-month-old beagles resulted in only two out of
four experimentally infected animals developing neutralizing
antibodies and no detectable viral RNA in organ tissues of
one euthanized animal 4 days postinfection. Viral RNA was
sporadically detected in the feces of these dogs a few days
postinfection (31). This same study shows that experimental
infection of SARS-CoV-2 was not successful in pigs, ducks, and
chickens (31). Taken together, these results raise the possibility
that companion animals, particularly cats and hamsters, may
get infected with SARS-CoV-2 outside experimental laboratory
conditions. As previously shown in a review on cell, tissue, and
animal models for SARS-CoV-2 infection, non-human primates
may be used for human clinical tests, while primary cell culture,
primary tissue explants, and organoids may be applied for other
human and animal approaches (35).
With millions of people detected with SARS-CoV-2
worldwide, reports of companion animals possibly infected
with the virus started to emerge. These animals were frequently
owned by individuals with confirmed or suspected SARS-
CoV-2 infection, raising concerns that an anthropozoonotic
transmission occurred. Therefore, our aim is to review reported
cases of animals naturally infected with SARS-CoV-2, particularly
companion pets, shedding light on the role of these animals in
the epidemiology of COVID-19.
A BRIEF OVERVIEW OF CORONAVIRUSES
Members of the Coronaviridae family have a positive-sense
single-stranded RNA genome varying from 26 to 32 kilobases,
the largest viral RNA genomes ever described. CoVs are
enveloped viruses and identified in several species of birds
and mammals, including humans. The Coronaviridae
family is composed of two subfamilies (Letovirinae and
Orthocoronavirinae) and four genera (Alphacoronavirus,
Betacoronavirus, Gammacoronavirus, and Deltacoronavirus)
found in the subfamily Orthocoronavirinae. The organization
and expression of their genome are very similar, with 15 to 16
non-structural proteins (nsp1 to nsp16, with nsp1 being absent in
Gammacoronavirus), codified by ORF1ab at the 5
′
end, and four
to six structural proteins, hemagglutinin-esterase (HE, found in
some betacoronaviruses) spike (S), envelope (E), membrane (M),
and nucleoprotein (N), which are codified by ORFs at the 3
′
end
of the genome (36, 37).
In humans, CoVs primarily cause infections of the
upper respiratory and gastrointestinal tracts, with clinical
manifestations ranging from asymptomatic to severe or lethal
(38). Seven CoV strains are able to infect humans: HCoV-NL63,
HCoV-229E (Alphacoronavirus), HCoV-OC43, HCoV-HKU1,
SARS-CoV-1, MERS-CoV, and more recently, SARS-CoV-2
(all these in the Betacoronavirus genus) (36, 38). HCoV-NL63,
Frontiers in Veterinary Science | www.frontiersin.org 2 October 2020 | Volume 7 | Article 591216
de Morais et al. SARS-CoV-2 in Companion Animals
HCoV-229E, HCoV-OC43, and HCoV-HKU1 are distributed
globally (39, 40), with seasonal and geographic variations. These
are low-pathogenic CoVs associated with a variety of mild
upper respiratory tract infections, occasionally affecting the
lower respiratory tract, leading to pneumonia, bronchiolitis,
or both (40–44). Nonetheless, in the last two decades, highly
pathogenic, zoonotic CoVs emerged. These are SARS-CoV-1,
which emerged in China in 2002 (9, 10); MERS-CoV (11), which
was first detected in Saudi Arabia in 2012 (11); and SARS-CoV-2
identified in China in 2019 (2, 3). These CoVs are highly
pathogenic and may cause lethal disease, with variable mortality
rates of about 10% for SARS-CoV-1, 34% for MERS-CoV, and
from 1 to 7% for SARS-CoV-2. The epidemic of SARS-CoV-1
affected 26 countries, and more than 8,000 cases were reported,
while MERS-CoV was identified in 27 countries, with more
than 80% of the 2,494 cases reported in Saudi Arabia (10, 45).
Currently, SARS-CoV-1 is not detected in any region of the
world, and MERS-CoV cases are sporadically reported in Saudi
Arabia (10, 45). SARS-CoV-2, on the other hand, is currently at
epidemic peaks in many regions, with exponential growth of case
numbers and fatalities globally (7).
Coronaviridae species affecting host species other than
humans have been reported, causing respiratory, gastrointestinal,
liver, kidney, or neurological diseases in a variety of domestic and
wild animals, with no human infection by these coronaviruses
ever reported. Among companion animals, canine coronavirus
(CCoV) and feline coronavirus (FCoV) belong to the species
Alphacoronavirus 1 with two serotypes (I and II), each occurring
as either a low-virulence biotype that causes mild to silent enteric
infectious and high-virulence, pantropic biotypes in dogs (a
CCoV-IIa lineage) and cats (feline infectious peritonitis virus)
(46, 47). In addition, a betacoronavirus named canine respiratory
coronavirus has been associated with respiratory disease in
dogs (48).
Among large animals, calves and adult cattle are susceptible
to enteric and respiratory disease after infection by bovine
coronavirus (a Betacoronavirus), while another betacoronavirus,
equine coronavirus, has been associated with enteric disease
in horses (49, 50). Avian coronavirus (a Gammacoronavirus)
has chickens as a natural host, infecting the trachea, lungs,
kidneys, reproductive tract, and intestines in broilers, layers, and
breeders with a wide range of serotypes (51, 52). Moreover,
swine acute diarrhea syndrome coronavirus (SADS-CoV), first
reported in 2017, together with porcine epidemic diarrhea virus
(PEDV) and transmissible gastroenteritis virus (TGEV) are
alphacoronaviruses that cause highly lethal enteric disease in pigs
(53). Porcine deltacoronavirus (PDCoV) and the betacoronavirus
porcine hemagglutinating encephalomyelitis virus (PHEV) also
use pigs as hosts (54, 55).
ACE-2 SIMILARITY AMONG DOMESTIC
ANIMALS AND HUMANS
To understand how certain domestic animal species may be
infected with SARS-CoV-2, it is crucial to investigate the
underlying reason for the ability of the virus to enter host cells
and establish infection. Current knowledge of the SARS-CoV-2
pathogenesis indicates that such event is made possible by the
interaction between SARS-CoV-2 and the host ACE-2 protein,
which acts as a receptor for viral adherence andmembrane fusion
(19–22). Supplementary Data and Table 1 show a multiple
protein sequence alignment of ACE-2 of human, main domestic,
and laboratory animal species and cross-species identity of the 22
amino acids of ACE-2 that physically interact with SARS-CoV-
2 (22), respectively. Among putative pet animals, golden Syrian
hamsters, cats, and rabbits diverge in only 3 of the 22 amino
acids of ACE-2 responsible for the interaction with SARS-CoV-
2, while dogs diverge in five amino acids (Supplementary Data
and Table 1). However, the whole-protein sequence of ACE-2 of
golden Syrian hamsters showed higher sequence similarity and
phylogenetic relatedness to human ACE-2 than the rabbit and
cat ACE-2 (Supplementary Figure 1). Whether at the whole-
protein level or at the 22 interaction-defining amino acids, this
sequencemay be determinant of a successful infection, along with
the expression of ACE-2 protein in different tissues and yet to
be unraveled alternative receptors of SARS-CoV-2 in host cells.
The link between structural properties of ACE-2 orthologs to
SARS-CoV-2 spike protein has been already investigated (56). In
this study, non-conservative mutations in several ACE-2 amino
acid residues have been associated with interrupted key polar
and charged viral spike protein contacts, which may decrease the
susceptibility to SARS-CoV-2 infection across different animal
species. In addition, structural analysis of amino acid residues has
suggested that changes in amino acid positions 30 and 83 may
affect structural interaction of ACE-2 and SARS-CoV-2 RBD,
differentiating non-susceptible from susceptible species (57).
SARS-COV-2 IN ANIMALS
Dogs
The first report of SARS-CoV-2 infection in dogs occurred in
Hong Kong, China, by the Hong Kong Agriculture, Fisheries,
and Conservation Department (AFCD) (58) (Table 2). A 17-
year-old male Pomeranian with several comorbidities was
asymptomatic and quarantined on February 26, 2020, after its
owner was diagnosed with COVID-19 (58, 59). On March 18,
an asymptomatic 2.5-year-old male German shepherd dog tested
positive for SARS-CoV-2 by RT-qPCR in nasal and oral swabs;
the two dogs had detectable antibodies against SARS-CoV-2
(60, 61). In addition, viral sequences were identical to the virus
identified in the respective owner cases, suggesting human-
to-animal transmission (72). On June 1, in the Netherlands,
neutralizing antibodies against SARS-CoV-2 were detected in
an 8-year-old American bulldog with breathing distress, with a
COVID-19-positive owner (62). The animal was euthanized due
to clinical worsening (71). In New York State, Richmond County,
USA, two dogs tested positive to anti-SARS-CoV-2 antibodies
(62). One dog showed signs of respiratory illness and severe
lethargy associated with hemolytic anemia (62). The other dog
was asymptomatic. The owner of the two dogs tested positive for
COVID-19 (62). Both dogs are recovering (62). In May 2020, a 7-
year-old male German Shepherd tested positive for SARS-CoV-2
by RT-qPCR, after 6 weeks with breathing distress (73). On July
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TABLE 1 | Cross-species identity of the 22 amino acids of the angiotensin-converting enzyme-2 (ACE-2) identified as directly involved in the physical interaction of ACE-2
and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as defined by Shang et al. (22).
Amino acid position in the human ACE-2
Host 19 24 27 28 31 34 35 37 38 41 42 45 79 82 83 325 329 330 353 354 355 357 Total
Human S Q T F K H E E D Y Q L L M Y Q E N K G D R 22/22
Rhesus monkey S Q T F K H E E D Y Q L L M Y Q E N K G D R 22/22
Chimpanzee S Q T F K H E E D Y Q L L M Y Q E N K G D R 22/22
Syrian hamster S Q T F K Q E E D Y Q L L N Y Q E N K G D R 20/22
Domestic cat S L T F K H E E E Y Q L L T Y Q E N K G D R 19/22
Cow S Q T F K H E E D Y Q L M T Y Q D N K G D R 19/22
Sheep S Q T F K H E E D Y Q L M T Y Q D N K G D R 19/22
Rabbit S L T F K Q E E D Y Q L L T Y Q E N K G D R 19/22
Chinese hamster S Q T F K Q E E D Y Q L L N Y Q G N K G D R 18/22
Pangolin S E T F K S E E E Y Q L I N Y Q E N K H D R 17/22
Domestic dog S L T F K Y E E E Y Q L L T Y Q G N K G D R 17/22
Horse S L T F K S E E E H Q L L T Y Q E N K G D R 17/22
Pig S L T F K L E E D Y Q L I T Y Q N N K G D R 17/22
Ferret S L T F K Y E E E Y Q L H T Y E Q N K R D R 14/22
Mice* S N T F N Q E E D Y Q L T S F Q A N H G D R 14/22
G. horseshoe bat** S L K F D S E E N H Q L L N F E N N K G D R 13/22
Chicken S - T F E V R E D Y E L N R F E T N K N D R 12/22
*Mus musculus. **Greater horseshoe bat. Total = number of identical amino acid residues compared to the human ACE-2 reference amino acids. Accession numbers of protein
sequences: NP_001358344.1 (human, Homo sapiens); NP_001116542.1 (pig, Sus scrofa); NP_001019673.2 (cow, Bos taurus); NP_001158732.1 (domestic dog; Canis lupus familiaris);
NP_001034545.1 (domestic cat, Felis catus); XP_416822.2 (chicken; Gallus gallus); XP_011961657.1 (sheep; Ovis aries); XP_003503283.1 (Chinese hamster; Cricetulus griseus);
NP_001123985.1 (mice, Mus musculus); XP_002719891.1 (rabbit; Oryctolagus cuniculus); XP_016798468.1 (chimpanzee, Pan troglodytes); NP_001129168.1 (Rhesus monkey;
Macaca mulatta); NP_001297119.1 (European domestic ferret, Mustela putorius furo); XP_005074266.1 (golden Syrian hamster, Mesocricetus auratus); XP_001490241.1 (horse,
Equus caballus); XP_017505752.1 (pangolin, Manis javanica); XP_032963186.1 (greater horseshoe bat; Rhinolophus ferrumequinum). Whole-protein sequence alignment can be found
in the Supplementary Data. Amino acid residues are the ones in contact with the receptor binding domain (RBD) of SARS-CoV-2 and directly involved in the RBD–ACE-2 binding.
Positions were retrieved from Shang et al. (22). Overall protein identity/similarity against human ACE-2 of chimpanzee = 99.0/99.4%; Rhesus monkey = 94.9/97.5%; golden Syrian
hamster= 84.5/91.7%; domestic cat= 81.7/88.3%; cow= 81.0/90.6%; sheep= 81.7/90.8%; rabbit= 85.2/92.8%; Chinese hamster= 84.3/91.6%; pangolin= 84.8/91.3%; domestic
dog = 83.5/91.8%; horse = 86.8/93.4%; pig = 81.4/90.7%; ferret = 82.6/91.6%; mice = 82.1/89.6%; greater horseshoe bat = 81.5/90.3%; chicken = 65.6/79.3%. Pairwise protein
identities and similarities were calculated using the Needleman–Wunsch algorithm from the European Bioinformatics Institute (EMBL-EBI) available at https://www.ebi.ac.uk/Tools/psa/
emboss_needle/ using default parameters.
11, 2020, the animal died with a diagnosis of lymphoma, which
may have been a confounding cause for the respiratory signs (73).
Cats
Also, in Hong Kong, nasal and oral swab and fecal samples from a
clinically healthy cat tested positive for SARS-CoV-2 by RT-qPCR
(74). The owner had been hospitalized with COVID-19 (63).
Until April 15, 2020, the Hong Kong Agriculture, Fisheries, and
Conservation Department tested 17 cats from guardians positive
for COVID-19, and only the cat mentioned above was positive
(62). In mid-March 2020, in Belgium, viral RNA from SARS-
CoV-2 was detected in samples of vomit and feces of a cat with
diarrhea, vomiting, and dyspnea, using RT-qPCR (64). Despite
the animal’s guardian being infected with COVID-19, it was not
possible to establish the level of identity between the genomic
sequences of SARS-CoV-2 present in the cat and human (64).
This cat showed clinical improvement 9 days after the onset of
symptoms (64).
On April 22, the OIE, the Centers for Disease Control
and Prevention (CDC), and the United States Department of
Agriculture (USDA) reported that two cats from the New York
I State in the USA, both presenting sneezing and nasal discharge,
tested positive for SARS-CoV-2 by RT-qPCR (68, 69). One cat is a
5-year-old Devon Rex, from Orange County, and the owner was
positive for COVID-19 (75). The clinical signs in the cat appeared
after the owner showed COVID-19-compatible symptoms (75).
Another cat in the same household remained asymptomatic but
was not tested for the presence of the virus (75). The second
positive 4-year-old cat was from Long Island (Nassau County)
with outdoor access (75). The animal has presented respiratory
signs and lethargy and tested positive to SARS-CoV-2 RNA
by quantitative RT-PCR. Three of five households have shown
clinical signs related to COVID-19 but were not tested, and the
cat is presumed to have been infected by someone at home or by
a virus carrier (75). The latest laboratory tests on the two cats have
shown that they are clearing the infection and will likely have full
recovery (75).
On March 18, a case of a Belgian cat with a breathing
problem, vomiting, and diarrhea was reported, with SARS-
CoV-2 detected by RT-qPCR in vomit and feces samples (76).
On April 17, a 9-year-old female cat of European breed from
France was tested positive to SARS-CoV-2 RNA by RT-qPCR
on a rectal swab. The animal showed clinical signs, such as
anorexia, vomiting, and cough, 17 days after its owner has
Frontiers in Veterinary Science | www.frontiersin.org 4 October 2020 | Volume 7 | Article 591216
de Morais et al. SARS-CoV-2 in Companion Animals
TABLE 2 | Reports of SARS-CoV-2 natural infection in animals worldwide, to date.












1/1 (100.0) (58, 59)




1/1 (100.0) (60, 61)
March to April,
2020
Cat Hong Kong/China No Nasal, oral, and fecal
swabs
RT-qPCR 1/17 (5.9) (62, 63)
March 18, 2020 Cat Belgium Yes Vomit and feces
samples
RT-qPCR 1/1 (100.0) (64)
April 4, 2020 Tiger New York
City/USA
Yes Nasal and oral swabs RT-qPCR 4/5 (80.0) (65)
April 4, 2020 Lion New York
City/USA
Yes Nasal and oral swabs RT-qPCR 3/3 (100.0) (66)
April, 17 2020 Cat France Yes Rectal swab RT-qPCR; MIA** 1/22 (4.5) (67)
April, 22 2020 Cat New York
State/USA
Yes Nasal swabs RT-qPCR 2/2 (100.0) (68, 69)
April 26, 2020 Mink Netherlands Yes Nasal, oral, and rectal
swabs
RT-qPCR 7/7 (100.0) (70)
July 1, 2020 Dog Netherlands Yes Serum samples Serological test 1/1 (100.0) (71)
July 2, 2020 Dog New York State,
Richmond
County/USA
Yes (1/2; 50.0) Serum samples Serological test 2/2 (100.0) (62)
*PRN, plaque reduction neutralization test. **MIA, microsphere immunoassay.
tested positive to COVID-19. Antibodies against SARS-CoV-
2 have been detected in two serum samples taken 10 days
separately. In addition, sequence analysis of cat SARS-CoV-2
has shown that it belongs to the phylogenetic clade A2a, similar
to the French human SARS-CoV-2 (67). In June, one cat from
Minnesota and another one from Illinois, USA, tested positive for
SAR-CoV-2, confirmed by USDA’s National Veterinary Services
Laboratories (77).
It is not surprising that cats develop clinical signs; SARS-
CoV-2 penetrates the cell by binding to the ACE-2 receptor,
and the ACE-2 receptor in cats has high homology with the
human receptor (78–80), as shown above. The coronavirus that
caused the SARS epidemic (SARS-CoV-1) in 2003 also uses
the ACE-2 receptor to enter cells (81). Cats are susceptible to
experimental infection with the SARS-CoV-1 and also became
naturally infected during the SARS epidemic in 2003 (81, 82).
Recently, cats were experimentally inoculated intranasally with
high doses of SARS-CoV-2 (31). The animals showed no clinical
signs, developed neutralizing antibodies, and eliminated viral
RNA in the feces. At necropsy, infectious virus was found
in the nasal turbinates, soft palate, tonsils, trachea, and lungs
(31). Experimentally infected cats transmitted the disease by
air particles to susceptible cats (31). Moreover, an experimental
study has shown that SARS-CoV-2 was transmitted by virus-
inoculated cats to cats with no previous infection, after cohoused
contact. After 24 days of inoculation, all the cats showed IgG
antibody titers ranging from 5,120 to 20,480. Since no clinical
signs were reported in this study, the authors speculate that cats
may be a silent intermediate host of SARS-CoV-2 (34).
Other Animals
Experimental infection with SARS-CoV-2 is also possible
in hamsters, ferrets, rhesus macaques (Macaca mulatta),
cynomolgus monkeys (Macaca fascicularis), and African
green monkeys (Chlorocebus sabaeus) (31–33, 83–86).
Callithrix jacchus monkeys have been resistant to SARS-CoV-2
experimental infection, when compared with M. fascicularis and
M. mulatta (87). Experimental studies with rhesus macaques
have shown mild disease as frequently observed in human cases
(83) and suggest that primary SARS-CoV-2 infection protects
against reinfection throughout early recovery days (88).
In hamsters and ferrets, transmission occurred to other
susceptible animals by air (31, 32). To date, there are no reports of
natural cases of SARS-CoV-2 infection in hamsters or ferrets (31,
32). The Hong Kong Agriculture, Fisheries, and Conservation
Department tested two hamsters from guardians positive for
SARS-CoV-2, and both were negative (62). Under experimental
conditions, Syrian hamsters (M. auratus) have been successfully
infected by SARS-CoV-2, and transmission between cohoused
animals was observed by direct or indirect contact with blood,
feces, saliva, and tears (27).
On April 4, 2020, the US Department of Agriculture (USDA)
announced that samples from a 4-year-old female Malayan tiger
at the Bronx Zoo in New York City tested positive for SARS-
CoV-2 by RT-qPCR (89). The swab samples were collected and
tested after two Malayan tigers, three Siberian tigers, and three
African lions showed respiratory signs for a week (65, 89). On
April 17, the OIE confirmed that one of the African lions tested
positive for SARS-CoV-2 by RT-qPCR (66). Later on, all these
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animals and one asymptomatic Siberian tiger tested positive for
SARS-CoV-2 by RT-qPCR of stool samples (90). The five positive
tigers live separately in the same enclosure (90). The three lions
live in an enclosure in another zoo area, and they occasionally
interacted (90). The Bronx Zoo also has one Malayan tiger and
two Siberian tigers living in a distant enclosure (91). These three
tigers showed no clinical signs (91). SARS-CoV-2 was identified
and characterized in aMalayan tiger (92). The seven symptomatic
animals have improved and are expected to fully recover (91, 93).
In addition, SARS-CoV-2 characterization has shown distinct
viral sources for tigers and lions, with similarities between tiger
and zookeeper viruses suggesting human–animal transmission,
but no identified viral source was found for the infection in
lions (94).
On April 26, 2020, the Dutch Ministry of Agriculture, Nature,
and Food Quality communicated SARS-CoV-2 outbreak in
two mink (Neovison vison) farms, after respiratory disease and
increased mortality (70, 95). Infection by SARS-CoV-2 has been
reported in minks on a farm with 13,000 minks (95). Additional
infections were identified on a second farm with 7,500 adult
minks (96). Three minks with gastrointestinal and respiratory
signs were euthanized (70). Samples of manure, air, and dust
collected from the vicinity of the farm are being tested for the
presence of the virus (95, 96). Cats from the farms will also
be tested (95). At least one worker tested positive for SARS-
CoV-2 in both farms (70). It is not surprising that minks are
susceptible because they are from the same family (Mustelidae) as
ferrets (Mustela putorius furo), and ferrets can be experimentally
infected with SARS-CoV-2 and transmit the disease to other
ferrets by direct or indirect contact (32, 33). The infection
in minks appears to be a case of human-to-animal infection,
once viral sequences of two farms were related to human
being sequences, but in separate introductions (70). In addition,
since March 2020, rabbit farms near infected visons have been
investigated by the Dutch Ministry of Agriculture, Nature, and
Food Quality due to possible susceptibility to SARS-CoV-2 (97).
Experimental transmission study has shown that pigs (Sus
scrofa) and chickens (Gallus gallus) were not susceptible to SARS-
CoV-2, since none of the animals seroconverted and all samples
were negative for viral RNA after intranasal inoculation (98). On
the other hand, fruit bats (Rousettus aegyptiacus) have presented
virus replication detected by RT-PCR, in situ hybridization
(ISH), and immunohistochemistry (IHC) associated with mild
rhinitis (98).
DISCUSSION
It is important to emphasize that there is no transmission of
SARS-CoV-2 from pets to humans to date and that transmission
from people to pets is rare. In a study carried out by the Pasteur
Institute (France) published in April 2020, 21 domestic animals
were tested, including 9 cats and 12 dogs that lived in close
contact with their guardians, a total of 20 veterinary students
in France (99). Among the students, two tested positive for
SARS-CoV-2 by RT-PCR, and 11 out of 18 showed clinical
signs of COVID-19 (99). Among the animals, three cats showed
respiratory and gastrointestinal symptoms (99). Despite the
proximity to infected guardians, no dog or cat tested positive
for SARS-CoV-2 by RT-PCR nor showed antibodies to SARS-
CoV-2 in an immunoprecipitation assay (99). Despite the low
sampling, the study suggested that the transmission rate of SARS-
CoV-2 between humans and pets under natural conditions is
probably very low, below a reproduction number of 1 (99). So
far, there is no epidemiological study with a large number of
animals that allows estimating the percentage of dogs and cats
in contact with people with COVID-19 that excrete the virus or
develop antibodies.
Cats are known to be more susceptible to experimental
infection with SARS-CoV-2 than dogs (31). In 2016, 21% of New
York State households in the USA had cats with an estimated
total of 2,841,000 cats, and 21% of households had an average of
1.7 cats per house (100). As of May 9, 2020, the New York State
had 333,000 confirmed cases of COVID-19 (101). If those cases
were from different households, ∼103,000 cats would have been
exposed to patients with COVID-19, and only 2 of these 103,000
cats tested positive for SARS-CoV-2 (101). Cat population in the
area that would have been exposed to the virus was estimated.
Despite the impossibility of knowing how many cats have been
tested, evidences have shown that clinical disease may be rare in
cats. This suggests that transmission from people to animals is
really rare.
There are two serological surveys with cats, one of which also
includes dogs (102). In an unpublished study, 11 of 102 cats
had neutralizing antibodies against SARS-CoV-2, suggesting that
under natural conditions, cats exposed to SARS-CoV-2 develop
antibodies (103). These samples were obtained after the outbreak
of COVID-19 in Wuhan, China (103). In another serological
study also in the Wuhan region, antibodies to SARS-CoV-2 were
investigated in 35 animal species (102). The sampling included
15 pet dogs, 99 street dogs, 66 pet cats, and 21 street cats (102).
Close contact with a patient with COVID-19 was confirmed for
at least three dogs in this study (102). None of the dogs and cats
had antibodies against SARS-CoV-2 (102). It is possible that the
infected companion animals reported so far were in close contact
with humans emanating high viral loads of SARS-CoV-2, had
comorbidities or increased susceptibility to the virus, or had a
combination of these factors. It is assumed that the risk of animals
is greater at the beginning of the disease in people because this is
the time when the viral load is higher (104).
One must take into account that if a sustained transmission
naturally establishes among individuals of the same species,
SARS-CoV-2 might be led by natural selection to achieve a
higher fitness in this new species; the consequences of this event
remain unclear.
Many residents at the original epicenter of the Wuhan
outbreak were forced to leave their pets behind when authorities
removed people from their homes (105). Reports suggest that
owners left enough food and water for their pets to last for
some days (106). Several weeks later, many residents had not yet
returned home. In China, animal welfare organizations estimate
that in Hubei alone, tens of thousands of cats and dogs have
been left behind, facing hunger and death (105). The risk of pet
abandonment may increase due to reports of SARS-CoV-2 in
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dogs and cats, associated to lack of reliable information ruling
out dogs and cats as a source of infection. To investigate whether
the abandonment of domestic cats protects people against SARS-
CoV-2 infections, a computer model was created that simulates
a small community of human households and cats (107). A
different number of cats were set free during the simulations, and
the total number of infected people was recorded (107). In the
simulations, cats were chosen randomly, regardless of whether
they were positive or not, to simulate people in panic abandoning
their cats out of fear (107). After 2,000 simulations, it was
concluded that the number of infected people varies significantly
according to the number of abandoned cats (107). When no cat
was set free, 51 people on average were infected (107). For one
cat set free, 55 people were infected. For five set free, 62 were
infected. For 10 abandoned cats, 76 people in the community
were infected. This model suggests that abandoning cats can
increase the risk of infection among people. The model is still
rather superficial, and some of the assumptions are questionable
(107). The likelihood of infection from one cat to another cat
was considered to be the same as that of people to people,
while transmission between different species is approximately
half the probability (107). These values are probably overstated
when it comes to transmission between cats and transmission
interspecies (107). Still, this is a good example of a simulation
that can assist in risk assessment and decision making and in the
effect of changing some parameters on the incidence of new cases
in human patients (107).
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